My Alcon | Language

This page is available in English....

Select other country

TAKE CONTROL WITH RHOPRESSA®

(netarsudil ophthalmic solution) 0.02%

Get personalized support for your RHOPRESSA® treatment with the MyAlcon Together Patient Support program

    How does RHOPRESSA® work?

    Elevated IOP may result in glaucoma

     

    For people with open-angle glaucoma, fluid in the eye (called aqueous humor) does not drain properly. This elevates the pressure in the eye.

    Diagram of an eye graphic

    How can RHOPRESSA® help?

     

    RHOPRESSA® is a prescription medication for the reduction of high eye pressure in patients with open-angle glaucoma or ocular hypertension.

     

    • RHOPRESSA® helps increase the flow of fluid from the eye, which can lower the eye pressure

     

    Rhopressa daily control box and dropper

    Get more support for your RHOPRESSA® treatment by enrolling in the MyAlcon Together Patient Support program for offerings that are personalized just for you

    Savings & Support

     

    MyAlcon Together

     

    Enroll in the MyAlcon Together Patient Support program and choose customized support options that fit your needs:

    • MyAlcon Together nurses can provide telephone support and education in over 200 languages to answer general questions about glaucoma and your IOP-lowering treatment
    • Savings on your RHOPRESSA® prescription (for eligible, commercially insured patients)
    • Text or email reminders about topics like properly administering your medication, remembering prescription refills, and other useful resources
    Alcon prescription savings card

    Resources

     

    Glaucoma Glossary

     

    Learn some of the common terms you may often see when reading about glaucoma.

    Guide to Open-Angle Glaucoma

     

    A short guide to help you better understand your condition.

     

    Learn more about open-angle glaucoma

     

    American Academy of 
Ophthalmology

    How do I use RHOPRESSA®?

    RHOPRESSA® should be taken once daily in the evening

     

    • The recommended dose for RHOPRESSA® is one drop in the affected eye(s) once daily in the evening
    • If you miss a dose of RHOPRESSA®, you should continue with your next dose the following evening
    • If more than 1 eye drop is being used, the drugs should be administered at least 5 minutes apart
    • Contact lenses should be removed prior to the administration of RHOPRESSA® and may be reinserted 15 minutes after administration
    Nighttime eye drops icon & graphic

    Storing RHOPRESSA®

     

    • Keep the RHOPRESSA® bottle in the refrigerator  (36 °F to 46 °F) until opened
    • After opening, RHOPRESSA® may be kept at 36 °F to 77 °F for up to 6 weeks
    • If after opening, RHOPRESSA® is kept refrigerated at 36 °F to 46 °F, then the product can be used until the expiration date stamped on the bottle
    Refrigerator and Rhopressa eye dropper icon and graphic

    IOP=Intraocular pressure.

    INDICATION

    What is RHOPRESSA®?

    RHOPRESSA® (netarsudil ophthalmic solution) 0.02% is a prescription medicine to reduce high eye pressure (intraocular pressure, or IOP) in patients with open-angle glaucoma or ocular hypertension.

    IMPORTANT SAFETY INFORMATION

    • Avoid allowing the tip of the bottle to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solution.

     

    • If you develop another ocular condition (e.g., trauma or infection), have ocular surgery, or develop any ocular side effects, particularly conjunctivitis and eyelid reactions, you should immediately seek your healthcare provider’s advice about continuing to use RHOPRESSA®.
    • The preservative in RHOPRESSA®, benzalkonium chloride, may be absorbed by soft contact lenses. Contact lenses should be removed prior to instillation of RHOPRESSA®, but may be reinserted 15 minutes after instillation.
    • If you are using more than one eyedrop, the drugs should be administered at least 5 minutes apart.
    • The most common side effect of RHOPRESSA® in clinical trials was red eyes (53% of patients). Six percent of patients stopped taking RHOPRESSA® due to red eyes. Other common (approximately 20%) side effects were: small deposits on the outer surface of the eye, instillation site pain, and broken blood vessels on the white of the eye.

     

    For additional information about RHOPRESSA®, talk to your healthcare provider and click here to see the full Prescribing Information.

     

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.